
Kishor Mayekar
Examiner (ID: 18425, Phone: (571)272-1339 , Office: P/1759 )
| Most Active Art Unit | 1795 |
| Art Unit(s) | 1759, 1102, 1741, 1754, 1795, 2741, 1753 |
| Total Applications | 2436 |
| Issued Applications | 1650 |
| Pending Applications | 176 |
| Abandoned Applications | 610 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5944993
[patent_doc_number] => 20110105613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'MOISTURE RESISTANT CONTAINER SYSTEMS FOR RAPIDLY BIOAVAILABLE DOSAGE FORMS'
[patent_app_type] => utility
[patent_app_number] => 12/555975
[patent_app_country] => US
[patent_app_date] => 2009-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6960
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20110105613.pdf
[firstpage_image] =>[orig_patent_app_number] => 12555975
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/555975 | Moisture resistant container systems for rapidly bioavailable dosage forms | Sep 8, 2009 | Issued |
Array
(
[id] => 6621496
[patent_doc_number] => 20100324278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'RNA synthesis-phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3\'-end'
[patent_app_type] => utility
[patent_app_number] => 12/584625
[patent_app_country] => US
[patent_app_date] => 2009-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 11815
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20100324278.pdf
[firstpage_image] =>[orig_patent_app_number] => 12584625
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/584625 | RNA synthesis-phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end | Sep 7, 2009 | Issued |
Array
(
[id] => 9184086
[patent_doc_number] => 08624020
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-07
[patent_title] => 'Method for isolating and purifying nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 13/061928
[patent_app_country] => US
[patent_app_date] => 2009-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 21
[patent_no_of_words] => 8368
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13061928
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/061928 | Method for isolating and purifying nucleic acids | Sep 1, 2009 | Issued |
Array
(
[id] => 6026919
[patent_doc_number] => 20110054161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'METHODS OF PURIFYING A NUCLEIC ACID AND FORMULATION AND KIT FOR USE IN PERFORMING SUCH METHODS'
[patent_app_type] => utility
[patent_app_number] => 12/549806
[patent_app_country] => US
[patent_app_date] => 2009-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12924
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20110054161.pdf
[firstpage_image] =>[orig_patent_app_number] => 12549806
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/549806 | Methods of purifying a nucleic acid and formulation and kit for use in performing such methods | Aug 27, 2009 | Issued |
Array
(
[id] => 6477838
[patent_doc_number] => 20100041620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'METHODS FOR IMPROVING FRONTAL BRAIN BIOENERGETIC METABOLISM'
[patent_app_type] => utility
[patent_app_number] => 12/541452
[patent_app_country] => US
[patent_app_date] => 2009-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7489
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20100041620.pdf
[firstpage_image] =>[orig_patent_app_number] => 12541452
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/541452 | METHODS FOR IMPROVING FRONTAL BRAIN BIOENERGETIC METABOLISM | Aug 13, 2009 | Abandoned |
Array
(
[id] => 6048497
[patent_doc_number] => 20110207689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'THE TREATMENT OF HEARING LOSS'
[patent_app_type] => utility
[patent_app_number] => 13/058437
[patent_app_country] => US
[patent_app_date] => 2009-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 11095
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20110207689.pdf
[firstpage_image] =>[orig_patent_app_number] => 13058437
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/058437 | THE TREATMENT OF HEARING LOSS | Aug 10, 2009 | Abandoned |
Array
(
[id] => 6101633
[patent_doc_number] => 20110165125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'METHODS FOR ENHANCING ENERGY METABOLISM'
[patent_app_type] => utility
[patent_app_number] => 12/737721
[patent_app_country] => US
[patent_app_date] => 2009-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6144
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 52
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20110165125.pdf
[firstpage_image] =>[orig_patent_app_number] => 12737721
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/737721 | Methods for enhancing energy metabolism | Aug 9, 2009 | Issued |
Array
(
[id] => 6257641
[patent_doc_number] => 20100029692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'METHODS OF OPTIMIZING DRUG THERAPEUTIC EFFICACY FOR TREATMENT OF IMMUNE-MEDIATED GASTROINTESTINAL DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/535646
[patent_app_country] => US
[patent_app_date] => 2009-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11187
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029692.pdf
[firstpage_image] =>[orig_patent_app_number] => 12535646
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/535646 | Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders | Aug 3, 2009 | Issued |
Array
(
[id] => 5552099
[patent_doc_number] => 20090286085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'POLYMERIC BEADS FOR OLIGOMER SYNTHESIS'
[patent_app_type] => utility
[patent_app_number] => 12/510815
[patent_app_country] => US
[patent_app_date] => 2009-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31864
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20090286085.pdf
[firstpage_image] =>[orig_patent_app_number] => 12510815
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/510815 | POLYMERIC BEADS FOR OLIGOMER SYNTHESIS | Jul 27, 2009 | Abandoned |
Array
(
[id] => 5465696
[patent_doc_number] => 20090325896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 12/508385
[patent_app_country] => US
[patent_app_date] => 2009-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14789
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0325/20090325896.pdf
[firstpage_image] =>[orig_patent_app_number] => 12508385
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/508385 | PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS | Jul 22, 2009 | Abandoned |
Array
(
[id] => 6499575
[patent_doc_number] => 20100010336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-14
[patent_title] => 'METHOD AND SYSTEM FOR DIAGNOSIS OF NEUROPSYCHIATRIC DISORDERS INCLUDING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), AUTISM, AND SCHIZOPHRENIA'
[patent_app_type] => utility
[patent_app_number] => 12/508559
[patent_app_country] => US
[patent_app_date] => 2009-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 21041
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20100010336.pdf
[firstpage_image] =>[orig_patent_app_number] => 12508559
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/508559 | METHOD AND SYSTEM FOR DIAGNOSIS OF NEUROPSYCHIATRIC DISORDERS INCLUDING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), AUTISM, AND SCHIZOPHRENIA | Jul 22, 2009 | Abandoned |
Array
(
[id] => 5316454
[patent_doc_number] => 20090281052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'Indole Antiviral Compositions And Methods'
[patent_app_type] => utility
[patent_app_number] => 12/500311
[patent_app_country] => US
[patent_app_date] => 2009-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 29694
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20090281052.pdf
[firstpage_image] =>[orig_patent_app_number] => 12500311
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/500311 | Indole antiviral compositions and methods | Jul 8, 2009 | Issued |
Array
(
[id] => 6163036
[patent_doc_number] => 20110160158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'METHODS OF TREATMENT OF BIPOLAR DISORDER'
[patent_app_type] => utility
[patent_app_number] => 12/997296
[patent_app_country] => US
[patent_app_date] => 2009-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12022
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20110160158.pdf
[firstpage_image] =>[orig_patent_app_number] => 12997296
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/997296 | METHODS OF TREATMENT OF BIPOLAR DISORDER | Jun 11, 2009 | Abandoned |
Array
(
[id] => 5466014
[patent_doc_number] => 20090326214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'Crystalline Polymorphs of Gemcitabine Base'
[patent_app_type] => utility
[patent_app_number] => 12/483375
[patent_app_country] => US
[patent_app_date] => 2009-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 2632
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0326/20090326214.pdf
[firstpage_image] =>[orig_patent_app_number] => 12483375
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/483375 | Crystalline polymorphs of gemcitabine base | Jun 11, 2009 | Issued |
Array
(
[id] => 5534322
[patent_doc_number] => 20090234110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => '4\' -C-substituted-2-haloadenosine derivative'
[patent_app_type] => utility
[patent_app_number] => 12/453732
[patent_app_country] => US
[patent_app_date] => 2009-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13688
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20090234110.pdf
[firstpage_image] =>[orig_patent_app_number] => 12453732
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/453732 | 4' -C-substituted-2-haloadenosine derivative | May 19, 2009 | Issued |
Array
(
[id] => 5368447
[patent_doc_number] => 20090306006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'USE OF NICOTINIC ACID ADENINE DINUCLEOTIDE PHOSPHATE OR DERIVATIVE THEREOF AS AGENT FOR TREATING TYPE-2 DIABETES'
[patent_app_type] => utility
[patent_app_number] => 12/468600
[patent_app_country] => US
[patent_app_date] => 2009-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5469
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20090306006.pdf
[firstpage_image] =>[orig_patent_app_number] => 12468600
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/468600 | Use of nicotinic acid adenine dinucleotide phosphate or derivative thereof as agent for treating type-2 diabetes | May 18, 2009 | Issued |
Array
(
[id] => 5972546
[patent_doc_number] => 20110152214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'SILK POLYMER-BASED ADENOSINE RELEASE: THERAPEUTIC POTENTIAL FOR EPILEPSY'
[patent_app_type] => utility
[patent_app_number] => 12/991973
[patent_app_country] => US
[patent_app_date] => 2009-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15537
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20110152214.pdf
[firstpage_image] =>[orig_patent_app_number] => 12991973
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/991973 | Silk polymer-based adenosine release: therapeutic potential for epilepsy | May 14, 2009 | Issued |
Array
(
[id] => 5552766
[patent_doc_number] => 20090286752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/466213
[patent_app_country] => US
[patent_app_date] => 2009-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 35922
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20090286752.pdf
[firstpage_image] =>[orig_patent_app_number] => 12466213
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/466213 | Oral formulations of cytidine analogs and methods of use thereof | May 13, 2009 | Issued |
Array
(
[id] => 7567980
[patent_doc_number] => 20110288043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'MAINTENANCE OF PLATELET INHIBITION DURING ANTIPLATELET THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/990332
[patent_app_country] => US
[patent_app_date] => 2009-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6161
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20110288043.pdf
[firstpage_image] =>[orig_patent_app_number] => 12990332
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/990332 | Maintenance of platelet inhibition during antiplatelet therapy | May 12, 2009 | Issued |
Array
(
[id] => 7977639
[patent_doc_number] => 08071566
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-06
[patent_title] => 'Methods of coronary imaging'
[patent_app_type] => utility
[patent_app_number] => 12/435176
[patent_app_country] => US
[patent_app_date] => 2009-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 22
[patent_no_of_words] => 11584
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/071/08071566.pdf
[firstpage_image] =>[orig_patent_app_number] => 12435176
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/435176 | Methods of coronary imaging | May 3, 2009 | Issued |